Compound Summary
taurine
Compound Information
taurine
Compound Name: | taurine |
Compound CID: | 1123 |
Synonyms: | taurine 2-aminoethanesulfonic acid 107-35-7 L-Taurine Ethanesulfonic acid, 2-amino- More... |
Iupac Name: | 2-aminoethanesulfonic acid |
InChI: | InChI=1S/C2H7NO3S/c3-1-2-7(4,5)6/h1-3H2,(H,4,5,6) |
InChIKey: | XOAAWQZATWQOTB-UHFFFAOYSA-N |
Canonical Smiles: | C(CS(=O)(=O)O)N |
Isomeric Smiles: | C(CS(=O)(=O)O)N |
Molecular Weight: | 125.15 |
Molecular Formula: | C2H7NO3S |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
taurine
Molecular Weight: | 125.15 |
Molecular Formula: | C2H7NO3S |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 7 |
Complexity: | 120 |
Synonyms
taurine
| taurine | taurine |
|---|---|
taurine |
2-aminoethanesulfonic acid |
107-35-7 |
L-Taurine |
Ethanesulfonic acid, 2-amino- |
tauphon |
2-Aminoethylsulfonic acid |
2-aminoethane-1-sulfonic acid |
O-Due |
2-Sulfoethylamine |
taufon |
Aminoethanesulfonic acid |
aminoethylsulfonic acid |
beta-Aminoethylsulfonic acid |
Taurinum Latin |
Taurina Spanish |
FEMA No. 3813 |
Taurine INN |
CCRIS 4721 |
UNII-1EQV5MLY3D |
NCI-C60606 |
AI3-18307 |
NSC32428 |
1EQV5MLY3D |
2-aminoethane sulfonic acid |
.beta.-Aminoethylsulfonic acid |
1-Aminoethane-2-sulfonic acid |
CHEBI:15891 |
MFCD00008197 |
NSC-32428 |
NCGC00015997-06 |
DSSTox_CID_1304 |
DSSTox_RID_76069 |
DSSTox_GSID_21304 |
Taurine Hydrochloride |
2-amino-ethanesulfonic acid |
Taurina |
Taurinum |
C2H7NO3S |
CAS-107-35-7 |
SMR000326743 |
SR-01000076144 |
EINECS 203-483-8 |
NSC 32428 |
Taurine USP:INN:BAN |
Taurineold |
Taukard |
HSDB 8167 |
Aminoethylsulfonate |
Taurine,(S) |
Taurine (TN) |
b-Aminoethylsulfonate |
Taurine (8CI) |
2-Aminoethylsulfonate |
2-aminoethyl sulfonate |
beta-Aminoethylsulfonate |
Taurine-13C2 |
Tocris-0209 |
2aminoethanesulfonic acid |
Taurine, >=99% |
b-Aminoethylsulfonic acid |
Lopac-T-0625 |
WLN: Z2SWQ |
1-Aminoethane-2-sulfonate |
ACMC-2098vs |
bmse000120 |
bmse000805 |
bmse000863 |
EC 203-483-8 |
2-aminoethanesulfonic acid. |
Lopac0_001134 |
SCHEMBL23068 |
Taurine, >=98%, FG |
MLS000859681 |
MLS001332383 |
MLS001332384 |
ARONIS27193 |
Taurine (JP17/USP/INN) |
Aminoethylsulfonic acid (JAN) |
CHEMBL239243 |
GTPL2379 |
DTXSID3021304 |
Taurine, >=99.0% (T) |
HMS2093L13 |
HMS2233D19 |
HMS3263D09 |
HMS3370J18 |
Pharmakon1600-01505463 |
HY-B0351 |
RKL10149 |
ZINC3809490 |
Tox21_110277 |
Tox21_202520 |
Tox21_501134 |
BDBM50357220 |
NSC759150 |
s2008 |
STL197941 |
AKOS005208848 |
Tox21_110277_1 |
CCG-205208 |
DB01956 |
Ethanesulfonic acid, 2-amino- (9CI) |
LP01134 |
MCULE-6041857208 |
NSC-759150 |
SDCCGSBI-0051101.P003 |
Taurine, BioUltra, >=99.5% (T) |
Taurine, SAJ first grade, >=98.5% |
NCGC00015997-01 |
NCGC00015997-02 |
NCGC00015997-03 |
NCGC00015997-04 |
NCGC00015997-05 |
NCGC00015997-07 |
NCGC00015997-08 |
NCGC00015997-10 |
NCGC00015997-20 |
NCGC00024497-01 |
NCGC00024497-02 |
NCGC00024497-03 |
NCGC00024497-04 |
NCGC00024497-05 |
NCGC00260069-01 |
NCGC00261819-01 |
AS-13587 |
I815 |
NCI60_002814 |
SBI-0051101.P002 |
Taurine, Vetec(TM) reagent grade, >=99% |
A0295 |
AM20080018 |
B1846 |
EU-0101134 |
FT-0611241 |
T-130 |
C00245 |
D00047 |
D78121 |
T 0625 |
AB00443712-07 |
AB00443712_09 |
AB00443712_10 |
Q207051 |
J-508042 |
SR-01000076144-1 |
SR-01000076144-3 |
SR-01000076144-5 |
Taurine, certified reference material, TraceCERT(R) |
F2191-0280 |
Z1317839154 |
Taurine, cell culture tested, meets USP testing specifications |
Taurine, United States Pharmacopeia (USP) Reference Standard |
Taurine, Pharmaceutical Secondary Standard; Certified Reference Material |
Taurine, PharmaGrade, Ajinomoto, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production, suitable for cell culture |
Experimental Data
taurine
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 5.000000000000000 | mM | 6.000000000000000 | S | N2 | 25643626 | Active | ||||||
| Drosophila melanogaster | 0.400000000000000 | % | 32.000000000000000 | 32.000000000000000 | 0.000000000000000 | NS | N2 | 29093334 | Inactive | ||||
| Drosophila melanogaster | 1.600000000000000 | % | 32.000000000000000 | 26.000000000000000 | -0.190000000000000 | S | N2 | 29093334 | Inactive | ||||
| Drosophila melanogaster | 0.800000000000000 | % | 32.000000000000000 | 35.000000000000000 | 0.090000000000000 | S | N2 | 29093334 | Active | ||||
| Caenorhabditis elegans | 1.000000000000000 | mM | 11.000000000000000 | S | N2 | 25643626 | Active | ||||||
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 0.000000000000000 | NS | N2 | 24134630 | Inactive | ||||||
| Drosophila melanogaster | 2.000000000000000 | mg/mL | 64.970000000000000 | 61.830000000000000 | -4.800000000000000 | NS | 33920365 | Inactive | |||||
| Drosophila melanogaster | 1.000000000000000 | mg/mL | 64.970000000000000 | 66.810000000000000 | 2.810000000000000 | NS | 33920365 | Inactive | |||||
| Drosophila melanogaster | 0.250000000000000 | mg/mL | 64.970000000000000 | 67.940000000000000 | 4.570000000000000 | NS | 33920365 | Inactive | |||||
| Caenorhabditis elegans | 10.000000000000000 | mM | -4.000000000000000 | S | N2 | 25643626 | Inactive | ||||||
| Drosophila melanogaster | 8.000000000000000 | mg/mL | 64.970000000000000 | 70.140000000000000 | 7.950000000000000 | NS | 33920365 | Inactive | |||||
| Drosophila melanogaster | 32.000000000000000 | mg/mL | 64.970000000000000 | 66.040000000000000 | 1.600000000000000 | NS | 33920365 | Inactive |
Experimental Data Visualization
taurine
Statistics Data
taurine
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 11.000000000000000 | 2 | 4 | |
| Drosophila melanogaster | 7.950000000000000 | 2 | 8 |
Statistics Data Visualization
taurine
